| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 179 |
| 1 | RITUXIMAB | 127 |
| 2 | CYCLOPHOSPHAMIDE | 87 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 87 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 87 |
| 5 | CLOPIDOGREL BISULFATE | 83 |
| 6 | CLOPIDOGREL | 79 |
| 7 | PANTOPRAZOLE | 79 |
| 8 | FUROSEMIDE | 64 |
| 9 | ASPIRIN | 61 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAXOLOL HYDROCHLORIDE | 6 | 0.0115 |
| 1 | BETAXOLOL | 8 | 0.0098 |
| 2 | ANTI-INHIBITOR COAGULANT COMPLEX | 6 | 0.0054 |
| 3 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 4 | CHLORPROMAZINE HYDROCHLORIDE | 3 | 0.0031 |
| 5 | CLOMIPRAMINE HYDROCHLORIDE | 12 | 0.0026 |
| 6 | TAFAMIDIS MEGLUMINE | 12 | 0.0025 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 2 | 0.0023 |
| 8 | GINKGO BILOBA | 3 | 0.0021 |
| 9 | ANAGRELIDE HYDROCHLORIDE | 2 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 240 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 160 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 130 |
| 3 | Proton Pump Inhibitor [EPC] | 90 |
| 4 | Alkylating Drug [EPC] | 87 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 85 |
| 6 | Loop Diuretic [EPC] | 70 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 61 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 47 |
| 9 | Opioid Agonist [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 25 | 0.0013 |
| 2 | Radioligand Therapeutic Agent [EPC] | 14 | 0.0010 |
| 3 | Quinolone Antimicrobial [EPC] | 7 | 0.0007 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 85 | 0.0007 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 4 | 0.0006 |
| 6 | Nonergot Dopamine Agonist [EPC] | 10 | 0.0006 |
| 7 | Muscle Relaxant [EPC] | 21 | 0.0005 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 14 | 0.0004 |